ASCO Mourns Tragic Loss of Board Member Dr. Arti Hurria

Article

In Partnership With:

ASCO and the entire oncology community are deeply saddened by the loss of colleague, friend, ASCO Board of Directors member, and geriatric oncology leader Arti Hurria, MD, FASCO.

Arti Hurra, MD, FASCO

Arti Hurria, MD, FASCO, ASCO Board of Directors member, geriatric oncology leader

Arti Hurria, MD, FASCO

ASCO and the entire oncology community are deeply saddened by the loss of colleague, friend, ASCO Board of Directors member, and geriatric oncology leader Arti Hurria, MD, FASCO. Dr. Hurria was killed in a traffic accident on November 6, 2018. She was the George Tsai Family Chair in Geriatric Oncology, director of the Center on Cancer and Aging, co-lead of the Cancer Control and Population Sciences Program, vice provost of clinical faculty, a professor in the Department of Medical Oncology & Therapeutics Research, and a medical oncologist at City of Hope.

Related Videos
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer
Jasmin M. Zain, MD
Richard Kim, MD, an expert on colorectal cancer
A panel of 6 experts on colorectal cancer
Daneng Li, MD
In this fifth episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss next steps for research, including vaccination strategies, personalized cellular therapies, and more.
In this fourth episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss research efforts being made with organoids to address existing questions with immunotherapy and the exploration of multimodality approaches to improve outcomes.
In this third episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, discuss the potential benefits of utilizing immunotherapy approaches earlier on in the disease course.
In this second episode of OncChats: Leveraging Immunotherapy in GI Malignancies, Toufic Kachaamy, MD, of City of Hope, Sunil Sharma, MD, of City of Hope, and Madappa Kundranda, MD, PhD, of Banner MD Anderson Cancer Center, explain the challenges faced with preventing or detecting these cancers early and the understanding that is needed to develop effective early detection methods and move the needle forward.
Related Content
William Dale, MD, PhD, FASCO

ASCO Congratulates 2024 Special Awards Recipients

April 17th 2024
Article
Matthew Lunning, DO, FACP, associate professor, the Division of Oncology & Hematology, associate vice chair, research, the Department of Internal Medicine, assistant vice chancellor, clinical research, the University of Nebraska Medical Center

Lunning and Herrera Highlight Frontline Hodgkin Lymphoma Management Strategies

March 18th 2024
Podcast
Maurie Markman, MD

The Critical Nature of Decision-Making in the Development of Phase 3 Clinical Trials

April 12th 2024
Article
Diane M. Simeone, MD; Marwan G. Fakih, MD

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

December 18th 2023
Podcast
Richard T. Lee, MD, of City of Hope

Evidence-Based Integrative Oncology Approaches Forge a New Path in Cancer Care

April 1st 2024
Article
Maurie Markman, MD, president, Medicine & Science, City of Hope Atlanta, Chicago, and Phoenix

Is It Time to Address the Fiscal Reality of the Cancer Care Model and Consider Alternatives?

March 25th 2024
Article